How to treat pathologic cell behaviors - Mark Cooper, PhD (hons) MRPharmS (2021 Conference) (LDN, low dose naltrexone)

The role of immune modulation in cancer - Professor Angus Dalgleish (2021 Conference) (LDN, low dose naltrexone)

Jill Brook, MA - What the Bleep Can I Eat?! Making Sense of Conflicting Autoimmune Diets (2017 Conference) (LDN, low dose naltrexone)

Beth Livengood, ND - Gastroparesis Case Study (2017 Conference) (LDN, low dose naltrexone)

A case of gastroparesis and how low dose naltrexone helped this patient. Causes, symptoms, diagnostic findings, similar pathologies, demographics, and treatments, including diet, low dose naltrexone, acupuncture, etc; and the mechanisms of action of these treatments.

Debbie Rice, ND - LDN: regulating immune and inflammatory response (2017 Conference) (LDN, low dose naltrexone)

Two cases of Hashimoto's case where the patients stabilized on LDN. A Crohn’s case that took 3 months for LDN to have full effect

Cory Tichauer, ND - LDN and Lyme Disease II (2017 Conference) (LDN, low dose naltrexone)

Olga Cortez, MD - LDN Use in Women's Health I (2019 Conference) (LDN, low dose naltrexone)

Nasha Winters, ND - Using LDN to Quell the Over-Reactive Autoimmune Conditions Triggered by Many of Today's Cancer Drugs (2019 Conference) (LDN, low dose naltrexone)

Yoon Hang "John" Kim, MD - Treating chronic pain with low dose naltrexone and ultra low dose naltrexone (2019 Conference) (LDN, low dose naltrexone)

Steve Ottersberg, MS - LDN, pain and immunity (2019 Conference) (LDN, low dose naltrexone)